Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis.

Erpolat Ö. P., AKMANSU M., Goksel F., BORA H., Yaman E., Buyukberber S.

Tumori, cilt.95, sa.2, ss.191-7, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 95 Sayı: 2
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1177/030089160909500210
  • Dergi Adı: Tumori
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.191-7
  • Anahtar Kelimeler: adjuvant, concomitant, glioblastoma, radiotherapy, temozolomide, PHASE-II, RADIATION-THERAPY, MULTIFORME, SURVIVAL, IRRADIATION, GLIOMAS, TRIAL
  • Gazi Üniversitesi Adresli: Evet

Özet

Aims and background. Glioblastoma is the most common primary brain tumor in adults. The standard treatment is surgery and radiotherapy. In this study, the results of radiotherapy plus concomitant and adjuvant temozolomide are reported. In addition, the efficiency of adjuvant temozolomide is evaluated.